- Report
- March 2024
- 191 Pages
Global
From €3217EUR$3,374USD£2,749GBP
€3574EUR$3,749USD£3,054GBP
- Report
- May 2024
- 92 Pages
Global
From €5339EUR$5,600USD£4,562GBP
- Report
- November 2023
- 182 Pages
Global
From €4672EUR$4,900USD£3,992GBP
- Report
- January 2024
- 150 Pages
Global
From €4624EUR$4,850USD£3,951GBP
- Report
- November 2023
- 250 Pages
Global
From €4767EUR$5,000USD£4,073GBP
- Report
- January 2024
- 220 Pages
Global
From €2374EUR$2,490USD£2,028GBP
- Report
- December 2023
- 88 Pages
Global
From €4719EUR$4,950USD£4,032GBP
- Report
- August 2023
- 145 Pages
Global
From €3003EUR$3,150USD£2,566GBP
- Report
- March 2023
- 450 Pages
Global
From €4785EUR$5,194USD£3,950GBP
- Report
- June 2023
- 100 Pages
Brazil
From €3766EUR$3,950USD£3,218GBP
- Report
- November 2022
- 187 Pages
Global
From €5673EUR$5,950USD£4,847GBP
- Report
- February 2023
- 100 Pages
Global
From €2622EUR$2,750USD£2,240GBP
- Report
- February 2024
- 92 Pages
Global
From €3500EUR$3,932USD£3,095GBP
The Therapeutic Respiratory Devices market is a subset of the larger Respiratory Devices market. It includes devices used to treat respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These devices are used to deliver medication, humidify air, and provide oxygen therapy. They can also be used to monitor lung function and detect early signs of respiratory distress.
Therapeutic Respiratory Devices are typically used in hospitals, clinics, and home settings. They are designed to improve patient comfort and quality of life, as well as reduce the risk of complications from respiratory diseases.
Some companies in the Therapeutic Respiratory Devices market include Philips Respironics, ResMed, Fisher & Paykel Healthcare, and Vyaire Medical. Show Less Read more